Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Travis Batts

Cardiovascular Disease Jbsa Lackland, TX Medical Doctor

NPI 1164646394 CMS profile 453636

1100 Wilford Hall Loop, Bldg 4554, Jbsa Lackland, TX 78236

Open in the dashboard

General payments

$457,023

434 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Travis Batts of Jbsa Lackland, TX is reported in the CMS Open Payments database as having received $457,023 across 434 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $77,182 69
2024 General $118,188 87
2023 General $62,995 86
2022 General $26,006 67
2021 General $25,931 30
2020 General $93,709 43
2019 General $53,013 52

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Travis Batts
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Travis Batts were reported at $77,182. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Travis Batts Cardiovascular Disease median Middle half National median
2019 $53,013 $450 $127–$1,392 $163
2020 $93,709 $242 $77–$751 $114
2021 $25,931 $335 $101–$1,037 $132
2022 $26,006 $395 $121–$1,211 $149
2023 $62,995 $443 $136–$1,283 $160
2024 $118,188 $450 $136–$1,323 $164
2025 $77,182 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $292,691 327 payments
  2. Novo Nordisk Inc $163,802 102 payments
  3. Edwards Lifesciences Corporation $221 1 payment
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $106 1 payment
  5. Chiesi USA, Inc. $98 1 payment
  6. Pfizer Inc. $87 1 payment
  7. Amgen Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $133,411 46 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $122,143 21 payments
  3. Honoraria $107,475 76 payments
  4. Travel and Lodging $50,344 146 payments
  5. Consulting Fee $20,985 6 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $13,475 5 payments
  7. Food and Beverage $9,125 132 payments
  8. Education $65 2 payments
Products named General payments · program years 2019–2025
  1. (1658) Clinical Educ Ultrasound $92,815 112 payments
  2. Wegovy $88,189 47 payments
  3. Educ Ultrasound $43,484 20 payments
  4. US Undivided Serv $42,005 29 payments
  5. (7881) Ultrasound Und $41,912 16 payments
  6. (1658) Educ Ultrasound $32,781 80 payments
  7. Clinical Educ Ultrasound $16,959 30 payments
  8. Ozempic $9,510 8 payments
  9. Clin Educ US $8,360 19 payments
  10. US Und $6,065 3 payments
  11. Other $8,840 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

434 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record